Viewing Study NCT07235059


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-01-02 @ 7:47 PM
Study NCT ID: NCT07235059
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-11-20
Start Date Type: ACTUAL
Primary Completion Date: 2027-07-19
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-07-19
Completion Date Type: ESTIMATED
First Submit Date: 2025-11-14
First Submit QC Date: None
Study First Post Date: 2025-11-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-23
Last Update Post Date: 2025-12-24
Last Update Post Date Type: ACTUAL